FDA approves Pharmaxis’ Bronchitol for cystic fibrosis as company looks to myelofibrosis Nov. 2, 2020 By Tamra Sami No Comments PERTH, Australia – With the approval of cystic fibrosis treatment Bronchitol (mannitol), Sydney-based Pharmaxis Ltd. joins a small group of elite Australian biotech companies to take their drugs all the way to FDA approval.Read More